Publication | Closed Access

Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: A key to study an angiogenic marker in vivo?

ThrombopoiesisThrombosisAngiogenesisHealth SciencesCardiovascular DiseaseBlood PlateletHematologyPlatelet Poor PlasmaPathologyVascular BiologyCancer PatientsNeovascularizationVascular Endothelial Growth FactorMedicineRadiation OncologyAtherosclerosisTumor MicroenvironmentAngiogenic Marker